 Charles Hoeffer
Concepts (291)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Long-Term Potentiation | 10 | 2017 | 145 | 2.070 |
Why?
| | Muscle Proteins | 4 | 2022 | 210 | 1.900 |
Why?
| | Intracellular Signaling Peptides and Proteins | 5 | 2015 | 386 | 1.640 |
Why?
| | Neuronal Plasticity | 11 | 2017 | 209 | 1.380 |
Why?
| | Protein Biosynthesis | 5 | 2021 | 386 | 1.320 |
Why?
| | Down Syndrome | 4 | 2022 | 335 | 1.290 |
Why?
| | Hippocampus | 11 | 2017 | 693 | 1.180 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2020 | 398 | 1.150 |
Why?
| | Memory | 6 | 2021 | 211 | 1.100 |
Why?
| | Behavior, Animal | 9 | 2023 | 458 | 1.070 |
Why?
| | Alzheimer Disease | 4 | 2022 | 442 | 1.000 |
Why?
| | Calcium-Binding Proteins | 3 | 2022 | 206 | 0.910 |
Why?
| | Brain | 4 | 2020 | 2371 | 0.870 |
Why?
| | Neurons | 9 | 2017 | 1280 | 0.870 |
Why?
| | Epistasis, Genetic | 1 | 2023 | 67 | 0.840 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2023 | 60 | 0.820 |
Why?
| | Chronobiology Disorders | 1 | 2022 | 12 | 0.800 |
Why?
| | DNA-Binding Proteins | 5 | 2023 | 1314 | 0.790 |
Why?
| | Spatial Memory | 1 | 2020 | 17 | 0.730 |
Why?
| | Dendritic Spines | 2 | 2021 | 49 | 0.720 |
Why?
| | Extinction, Psychological | 1 | 2020 | 78 | 0.680 |
Why?
| | Mice | 31 | 2023 | 14869 | 0.670 |
Why?
| | Interleukin-17 | 2 | 2017 | 104 | 0.660 |
Why?
| | Signal Transduction | 10 | 2016 | 4513 | 0.660 |
Why?
| | Aging | 2 | 2022 | 1618 | 0.660 |
Why?
| | Synapses | 8 | 2017 | 331 | 0.650 |
Why?
| | TOR Serine-Threonine Kinases | 6 | 2014 | 358 | 0.640 |
Why?
| | Animals | 39 | 2023 | 31706 | 0.630 |
Why?
| | Anxiety | 5 | 2023 | 840 | 0.600 |
Why?
| | Transcriptome | 1 | 2023 | 725 | 0.590 |
Why?
| | Tauopathies | 2 | 2016 | 9 | 0.570 |
Why?
| | Basolateral Nuclear Complex | 1 | 2017 | 11 | 0.560 |
Why?
| | Eukaryotic Initiation Factor-4E | 2 | 2021 | 27 | 0.560 |
Why?
| | Memory, Long-Term | 2 | 2020 | 11 | 0.550 |
Why?
| | Memory Consolidation | 1 | 2017 | 11 | 0.550 |
Why?
| | Fragile X Syndrome | 3 | 2012 | 64 | 0.540 |
Why?
| | Genome-Wide Association Study | 4 | 2023 | 1177 | 0.510 |
Why?
| | Nerve Degeneration | 1 | 2015 | 41 | 0.510 |
Why?
| | Autism Spectrum Disorder | 2 | 2017 | 322 | 0.500 |
Why?
| | Mice, Knockout | 15 | 2020 | 2570 | 0.470 |
Why?
| | Gene Expression Regulation | 6 | 2017 | 2320 | 0.470 |
Why?
| | Protein Synthesis Inhibitors | 2 | 2012 | 42 | 0.470 |
Why?
| | Up-Regulation | 2 | 2021 | 808 | 0.470 |
Why?
| | Sensory Gating | 2 | 2013 | 38 | 0.450 |
Why?
| | Fluoxetine | 1 | 2013 | 46 | 0.430 |
Why?
| | Disease Models, Animal | 11 | 2023 | 3535 | 0.430 |
Why?
| | GABAergic Neurons | 1 | 2013 | 21 | 0.430 |
Why?
| | Mental Disorders | 1 | 2020 | 892 | 0.420 |
Why?
| | Eukaryotic Initiation Factor-4F | 1 | 2012 | 1 | 0.420 |
Why?
| | Mice, Transgenic | 8 | 2018 | 1949 | 0.410 |
Why?
| | Sleep | 1 | 2018 | 631 | 0.410 |
Why?
| | Mitochondria | 2 | 2015 | 747 | 0.410 |
Why?
| | Gene Expression | 1 | 2017 | 1421 | 0.410 |
Why?
| | Protein Phosphatase 1 | 2 | 2013 | 29 | 0.410 |
Why?
| | Interneurons | 1 | 2013 | 97 | 0.410 |
Why?
| | Eukaryotic Initiation Factor-4G | 1 | 2011 | 5 | 0.370 |
Why?
| | Corticosterone | 1 | 2012 | 211 | 0.370 |
Why?
| | Mice, Inbred C57BL | 11 | 2020 | 4694 | 0.370 |
Why?
| | tau Proteins | 3 | 2016 | 66 | 0.360 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2012 | 367 | 0.340 |
Why?
| | Feces | 1 | 2012 | 373 | 0.330 |
Why?
| | Circadian Rhythm | 1 | 2012 | 354 | 0.320 |
Why?
| | Motor Activity | 3 | 2022 | 640 | 0.320 |
Why?
| | Raptors | 1 | 2008 | 2 | 0.320 |
Why?
| | Tacrolimus Binding Protein 1A | 1 | 2008 | 7 | 0.320 |
Why?
| | Phosphorylation | 9 | 2016 | 1569 | 0.300 |
Why?
| | Protein Isoforms | 2 | 2020 | 338 | 0.300 |
Why?
| | Maze Learning | 5 | 2014 | 86 | 0.300 |
Why?
| | Receptors, Metabotropic Glutamate | 4 | 2014 | 34 | 0.290 |
Why?
| | Fragile X Mental Retardation Protein | 4 | 2012 | 51 | 0.290 |
Why?
| | Fear | 3 | 2008 | 293 | 0.290 |
Why?
| | Protein Kinases | 2 | 2008 | 307 | 0.290 |
Why?
| | Memory Disorders | 3 | 2015 | 155 | 0.280 |
Why?
| | Nervous System Diseases | 1 | 2009 | 255 | 0.270 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2023 | 1880 | 0.270 |
Why?
| | RNA, Messenger | 3 | 2017 | 2553 | 0.270 |
Why?
| | Analysis of Variance | 4 | 2017 | 1226 | 0.260 |
Why?
| | Phenotype | 5 | 2023 | 2796 | 0.260 |
Why?
| | Male | 18 | 2023 | 55589 | 0.250 |
Why?
| | Hydrazones | 2 | 2017 | 21 | 0.240 |
Why?
| | Anti-Anxiety Agents | 2 | 2023 | 42 | 0.240 |
Why?
| | Mutation | 3 | 2016 | 3346 | 0.230 |
Why?
| | Thiazoles | 2 | 2017 | 110 | 0.230 |
Why?
| | In Vitro Techniques | 7 | 2014 | 1016 | 0.230 |
Why?
| | Cyclic GMP-Dependent Protein Kinase Type II | 2 | 2014 | 2 | 0.220 |
Why?
| | Diazepam | 1 | 2023 | 25 | 0.220 |
Why?
| | Gliosis | 1 | 2023 | 29 | 0.210 |
Why?
| | Rats, Sprague-Dawley | 4 | 2021 | 2218 | 0.210 |
Why?
| | RNA, Double-Stranded | 1 | 2023 | 44 | 0.210 |
Why?
| | Vesicular Transport Proteins | 1 | 2003 | 83 | 0.200 |
Why?
| | Suprachiasmatic Nucleus | 1 | 2022 | 12 | 0.200 |
Why?
| | Long-Term Synaptic Depression | 3 | 2014 | 48 | 0.200 |
Why?
| | Multifactorial Inheritance | 1 | 2023 | 122 | 0.200 |
Why?
| | Prefrontal Cortex | 2 | 2017 | 262 | 0.200 |
Why?
| | Neural Inhibition | 2 | 2017 | 140 | 0.200 |
Why?
| | Drosophila melanogaster | 1 | 2003 | 191 | 0.190 |
Why?
| | Gene Regulatory Networks | 1 | 2023 | 228 | 0.190 |
Why?
| | Cerebral Cortex | 2 | 2016 | 380 | 0.190 |
Why?
| | Artificial Intelligence | 1 | 2022 | 144 | 0.190 |
Why?
| | Neurodegenerative Diseases | 1 | 2022 | 93 | 0.190 |
Why?
| | Motor Neurons | 1 | 2023 | 213 | 0.180 |
Why?
| | Spatial Behavior | 1 | 2020 | 20 | 0.180 |
Why?
| | Spinal Cord | 1 | 2023 | 347 | 0.180 |
Why?
| | Receptors, Nicotinic | 2 | 2020 | 274 | 0.180 |
Why?
| | Cell Nucleus | 1 | 2003 | 554 | 0.180 |
Why?
| | Calcineurin | 2 | 2013 | 89 | 0.180 |
Why?
| | Anxiety Disorders | 1 | 2023 | 303 | 0.170 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 2 | 2013 | 127 | 0.170 |
Why?
| | Rats | 4 | 2021 | 4958 | 0.170 |
Why?
| | Synaptic Transmission | 2 | 2014 | 227 | 0.170 |
Why?
| | Behavior, Addictive | 1 | 2020 | 81 | 0.170 |
Why?
| | Genetic Markers | 1 | 2020 | 320 | 0.160 |
Why?
| | Amygdala | 2 | 2011 | 170 | 0.160 |
Why?
| | Memory, Short-Term | 2 | 2014 | 225 | 0.160 |
Why?
| | Electrocorticography | 1 | 2018 | 10 | 0.150 |
Why?
| | Conditioning, Classical | 2 | 2017 | 87 | 0.150 |
Why?
| | Brain Waves | 1 | 2018 | 21 | 0.150 |
Why?
| | Models, Biological | 3 | 2009 | 1620 | 0.140 |
Why?
| | Nerve Tissue Proteins | 2 | 2014 | 529 | 0.140 |
Why?
| | Polyribosomes | 1 | 2017 | 22 | 0.140 |
Why?
| | Wakefulness | 1 | 2018 | 128 | 0.140 |
Why?
| | Female | 9 | 2023 | 59499 | 0.140 |
Why?
| | Models, Animal | 2 | 2017 | 344 | 0.140 |
Why?
| | Neurofibrillary Tangles | 1 | 2016 | 13 | 0.140 |
Why?
| | Pyramidal Cells | 1 | 2017 | 51 | 0.140 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2017 | 135 | 0.130 |
Why?
| | CA1 Region, Hippocampal | 2 | 2014 | 29 | 0.130 |
Why?
| | Association Learning | 1 | 2017 | 60 | 0.130 |
Why?
| | Transcription Factors | 2 | 2022 | 1528 | 0.130 |
Why?
| | Sex Characteristics | 1 | 2020 | 640 | 0.130 |
Why?
| | Astrocytes | 1 | 2017 | 162 | 0.130 |
Why?
| | Dynamins | 1 | 2015 | 29 | 0.130 |
Why?
| | Th17 Cells | 1 | 2016 | 58 | 0.130 |
Why?
| | Nicotinic Agonists | 1 | 2017 | 100 | 0.130 |
Why?
| | Antipsychotic Agents | 2 | 2014 | 184 | 0.120 |
Why?
| | Alcoholism | 1 | 2021 | 713 | 0.120 |
Why?
| | Haloperidol | 2 | 2014 | 35 | 0.120 |
Why?
| | Pyridines | 3 | 2013 | 425 | 0.120 |
Why?
| | Maternal-Fetal Exchange | 1 | 2016 | 151 | 0.120 |
Why?
| | Neuroimaging | 1 | 2017 | 249 | 0.120 |
Why?
| | Humans | 16 | 2023 | 114674 | 0.120 |
Why?
| | Electric Stimulation | 3 | 2014 | 250 | 0.120 |
Why?
| | Nicotine | 1 | 2017 | 265 | 0.120 |
Why?
| | Antibodies | 1 | 2016 | 371 | 0.120 |
Why?
| | Social Behavior | 1 | 2017 | 267 | 0.120 |
Why?
| | eIF-2 Kinase | 1 | 2014 | 24 | 0.110 |
Why?
| | GABA-A Receptor Agonists | 1 | 2013 | 9 | 0.110 |
Why?
| | Excitatory Postsynaptic Potentials | 2 | 2011 | 98 | 0.110 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2014 | 144 | 0.110 |
Why?
| | Smoking | 1 | 2020 | 1383 | 0.110 |
Why?
| | Sterols | 1 | 2012 | 17 | 0.100 |
Why?
| | Nitro Compounds | 1 | 2012 | 6 | 0.100 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2013 | 106 | 0.100 |
Why?
| | Cell Count | 1 | 2013 | 303 | 0.100 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2017 | 683 | 0.100 |
Why?
| | Multiprotein Complexes | 1 | 2014 | 140 | 0.100 |
Why?
| | Sirolimus | 2 | 2011 | 181 | 0.100 |
Why?
| | Photoperiod | 1 | 2012 | 48 | 0.100 |
Why?
| | Reaction Time | 1 | 2013 | 376 | 0.100 |
Why?
| | Gene Deletion | 1 | 2013 | 356 | 0.100 |
Why?
| | Motor Skills | 1 | 2012 | 82 | 0.100 |
Why?
| | Amyloid beta-Peptides | 2 | 2011 | 189 | 0.100 |
Why?
| | Dopamine | 1 | 2014 | 236 | 0.100 |
Why?
| | Ribosomal Protein S6 | 1 | 2011 | 15 | 0.100 |
Why?
| | Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2011 | 9 | 0.100 |
Why?
| | Primary Cell Culture | 1 | 2012 | 149 | 0.090 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2014 | 156 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1518 | 0.090 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2008 | 36 | 0.090 |
Why?
| | Genotype | 2 | 2014 | 1760 | 0.090 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 130 | 0.090 |
Why?
| | Oxidants | 1 | 2011 | 112 | 0.090 |
Why?
| | Superoxides | 1 | 2011 | 214 | 0.090 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2016 | 452 | 0.090 |
Why?
| | Oxidative Stress | 1 | 2015 | 1076 | 0.080 |
Why?
| | Enzyme Inhibitors | 2 | 2011 | 750 | 0.080 |
Why?
| | Exploratory Behavior | 1 | 2008 | 82 | 0.080 |
Why?
| | Pregnancy | 2 | 2017 | 5518 | 0.080 |
Why?
| | Membrane Proteins | 1 | 2014 | 1019 | 0.080 |
Why?
| | Peptide Elongation Factor 1 | 1 | 2008 | 8 | 0.080 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2008 | 21 | 0.080 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2007 | 127 | 0.070 |
Why?
| | Space Perception | 1 | 2008 | 64 | 0.070 |
Why?
| | Activating Transcription Factor 4 | 1 | 2007 | 18 | 0.070 |
Why?
| | In Situ Hybridization | 1 | 2007 | 292 | 0.070 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2007 | 24 | 0.070 |
Why?
| | Eukaryotic Initiation Factors | 2 | 2021 | 9 | 0.070 |
Why?
| | Sex Factors | 1 | 2012 | 1715 | 0.070 |
Why?
| | Infant, Newborn | 1 | 2017 | 5045 | 0.070 |
Why?
| | Granulomatous Disease, Chronic | 1 | 2006 | 60 | 0.070 |
Why?
| | Cohort Studies | 1 | 2015 | 4895 | 0.060 |
Why?
| | Protein Binding | 1 | 2011 | 1890 | 0.060 |
Why?
| | Time Factors | 2 | 2012 | 6115 | 0.060 |
Why?
| | Carrier Proteins | 2 | 2010 | 695 | 0.060 |
Why?
| | Learning | 1 | 2008 | 350 | 0.060 |
Why?
| | N-Ethylmaleimide-Sensitive Proteins | 1 | 2003 | 5 | 0.060 |
Why?
| | Calcium-Transporting ATPases | 1 | 2003 | 34 | 0.050 |
Why?
| | Adult | 2 | 2017 | 30546 | 0.050 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2003 | 34 | 0.050 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2003 | 37 | 0.050 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2003 | 35 | 0.050 |
Why?
| | Neuromuscular Junction | 1 | 2003 | 53 | 0.050 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2003 | 110 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 113 | 0.050 |
Why?
| | Mice, Inbred Strains | 1 | 2023 | 396 | 0.050 |
Why?
| | Paralysis | 1 | 2003 | 66 | 0.050 |
Why?
| | Larva | 1 | 2003 | 194 | 0.050 |
Why?
| | Methoxyhydroxyphenylglycol | 2 | 2014 | 11 | 0.050 |
Why?
| | Species Specificity | 1 | 2023 | 542 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2003 | 278 | 0.050 |
Why?
| | Drosophila Proteins | 1 | 2003 | 164 | 0.050 |
Why?
| | Central Nervous System | 1 | 2003 | 235 | 0.050 |
Why?
| | Psychopathology | 1 | 2021 | 45 | 0.050 |
Why?
| | Temperature | 1 | 2003 | 565 | 0.040 |
Why?
| | Receptors, AMPA | 2 | 2012 | 119 | 0.040 |
Why?
| | Seizures | 1 | 2003 | 340 | 0.040 |
Why?
| | Bombyx | 1 | 2000 | 6 | 0.040 |
Why?
| | Apolipoproteins | 1 | 2000 | 36 | 0.040 |
Why?
| | Ultrasonography | 1 | 2003 | 634 | 0.040 |
Why?
| | NADPH Oxidase 2 | 2 | 2011 | 42 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 446 | 0.040 |
Why?
| | NADPH Oxidases | 2 | 2011 | 120 | 0.040 |
Why?
| | Child, Preschool | 1 | 2012 | 9114 | 0.040 |
Why?
| | Prepulse Inhibition | 1 | 2017 | 9 | 0.040 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2010 | 329 | 0.030 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2017 | 39 | 0.030 |
Why?
| | Young Adult | 1 | 2012 | 10466 | 0.030 |
Why?
| | Membrane Glycoproteins | 2 | 2011 | 430 | 0.030 |
Why?
| | Reflex, Startle | 1 | 2017 | 57 | 0.030 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 1 | 2017 | 96 | 0.030 |
Why?
| | CRISPR-Cas Systems | 1 | 2017 | 78 | 0.030 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2016 | 11 | 0.030 |
Why?
| | Antibodies, Blocking | 1 | 2016 | 32 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2017 | 397 | 0.030 |
Why?
| | Receptors, Retinoic Acid | 1 | 2016 | 49 | 0.030 |
Why?
| | Alcohol Drinking | 1 | 2021 | 651 | 0.030 |
Why?
| | Behavioral Symptoms | 1 | 2016 | 40 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 3886 | 0.030 |
Why?
| | Electrical Synapses | 1 | 2014 | 4 | 0.030 |
Why?
| | Tobacco Use Disorder | 1 | 2017 | 234 | 0.030 |
Why?
| | Biophysical Phenomena | 1 | 2014 | 63 | 0.030 |
Why?
| | Aged | 1 | 2012 | 19073 | 0.030 |
Why?
| | Adolescent | 1 | 2012 | 17841 | 0.030 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 96 | 0.030 |
Why?
| | Child | 1 | 2012 | 18412 | 0.030 |
Why?
| | Microtubule-Associated Proteins | 1 | 2014 | 174 | 0.030 |
Why?
| | Rotarod Performance Test | 1 | 2012 | 17 | 0.030 |
Why?
| | Post-Synaptic Density | 1 | 2012 | 11 | 0.030 |
Why?
| | Schizophrenia | 1 | 2017 | 414 | 0.030 |
Why?
| | Cyclic GMP | 1 | 2012 | 80 | 0.030 |
Why?
| | Middle Aged | 1 | 2012 | 26735 | 0.020 |
Why?
| | Gene Knock-In Techniques | 1 | 2011 | 46 | 0.020 |
Why?
| | Emetine | 1 | 2011 | 7 | 0.020 |
Why?
| | Onium Compounds | 1 | 2011 | 10 | 0.020 |
Why?
| | rap GTP-Binding Proteins | 1 | 2011 | 5 | 0.020 |
Why?
| | GABA-A Receptor Antagonists | 1 | 2011 | 14 | 0.020 |
Why?
| | Bicuculline | 1 | 2011 | 21 | 0.020 |
Why?
| | Ubiquinone | 1 | 2011 | 21 | 0.020 |
Why?
| | Electrophysiological Phenomena | 1 | 2011 | 48 | 0.020 |
Why?
| | Biphenyl Compounds | 1 | 2011 | 50 | 0.020 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2011 | 87 | 0.020 |
Why?
| | Flavonoids | 1 | 2011 | 66 | 0.020 |
Why?
| | Isoproterenol | 1 | 2011 | 106 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4099 | 0.020 |
Why?
| | Biophysics | 1 | 2011 | 69 | 0.020 |
Why?
| | Organophosphorus Compounds | 1 | 2011 | 72 | 0.020 |
Why?
| | Patch-Clamp Techniques | 1 | 2011 | 239 | 0.020 |
Why?
| | Adrenergic beta-Agonists | 1 | 2011 | 126 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-4A | 1 | 2010 | 2 | 0.020 |
Why?
| | Oncogene Protein v-akt | 1 | 2010 | 26 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2010 | 151 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2011 | 785 | 0.020 |
Why?
| | Serine | 1 | 2010 | 126 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2011 | 306 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2011 | 531 | 0.020 |
Why?
| | RNA 5' Terminal Oligopyrimidine Sequence | 1 | 2008 | 1 | 0.020 |
Why?
| | Autistic Disorder | 1 | 2010 | 162 | 0.020 |
Why?
| | Phosphoproteins | 1 | 2010 | 298 | 0.020 |
Why?
| | Antioxidants | 1 | 2011 | 530 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 157 | 0.020 |
Why?
| | Immunosuppressive Agents | 1 | 2011 | 646 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2011 | 1842 | 0.020 |
Why?
| | Peptide Fragments | 1 | 2010 | 666 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2010 | 551 | 0.020 |
Why?
| | Conditioning, Operant | 1 | 2006 | 97 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2010 | 476 | 0.020 |
Why?
| | Taste | 1 | 2008 | 208 | 0.020 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 180 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2000 | 256 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2000 | 1982 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2000 | 2785 | 0.010 |
Why?
|
|
Hoeffer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|